Actinium Pharmaceuticals, Inc. (NYSE: ATNM) went down by -2.59% from its latest closing price when compared to the 1-year high value of $0.87, while ATNM stocks collected +13.35% of gains with the last five trading sessions.

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Worth an Investment?

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) The 36 Months beta value for ATNM stocks is at 2.32, while 3 of the analysts out of 3 who provided ratings for Actinium Pharmaceuticals, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $4.25 which is $4.25 above current price. ATNM currently has a short float of 1.90% and public float of 114.14M with average trading volume of 1.46M shares.

ATNM Market Performance

ATNM stocks went up by 13.35% for the week, with the monthly drop of -1.65% and a quarterly performance of -45.55%, while its annual performance rate touched -19.17%. The simple moving average for the period of the last 20 days is 5.57% for ATNM stocks with the simple moving average of -44.19% for the last 200 days.

ATNM Stocks -29.74% Far from 50 Day Moving Average

After a stumble in the market that brought ATNM to its low price for the period of the last 52 weeks, Actinium Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -64.76% of loss for the given period.

The stock volatility was left at 8.13%, however, within the period of a single month, the volatility rate increased by 10.51%, while the shares surge at the distance of +3.36% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -45.55% lower at the present time.

In the course of the last 5 trading sessions, ATNM went up by +13.35%, which changed the moving average for the period of 200 days to the total of -53.09% of losses for the stock in comparison to the 20-day moving average settled at $0.29. In addition, Actinium Pharmaceuticals, Inc. saw -21.21% in overturn over the period of a single year with a tendency to cut further losses.

ATNM Stock Fundamentals

Based on Actinium Pharmaceuticals, Inc. (ATNM), the company’s capital structure generated 2.98 points for debt to equity in total, while total debt to capital is set at the value of 2.89. Total debt to assets is settled at the value of 1.76 with long-term debt to equity ratio rests at 0.15 and long-term debt to capital is 0.15.